These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 38156523)
1. Aging-Associated ALKBH5-m Chen R; Zhang G; Sun K; Chen AF J Am Heart Assoc; 2024 Jan; 13(1):e031353. PubMed ID: 38156523 [TBL] [Abstract][Full Text] [Related]
2. ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1. Han Z; Wang X; Xu Z; Cao Y; Gong R; Yu Y; Yu Y; Guo X; Liu S; Yu M; Ma W; Zhao Y; Xu J; Li X; Li S; Xu Y; Song R; Xu B; Yang F; Bamba D; Sukhareva N; Lei H; Gao M; Zhang W; Zagidullin N; Zhang Y; Yang B; Pan Z; Cai B Theranostics; 2021; 11(6):3000-3016. PubMed ID: 33456585 [TBL] [Abstract][Full Text] [Related]
3. The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy. Meng C; Su H; Shu M; Shen F; Lu Y; Wu S; Su Z; Yu M; Yang D Cell Death Dis; 2024 Sep; 15(9):683. PubMed ID: 39294131 [TBL] [Abstract][Full Text] [Related]
4. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner. Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928 [TBL] [Abstract][Full Text] [Related]
5. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma. Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767 [TBL] [Abstract][Full Text] [Related]
6. Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A. Zhao Y; Hu J; Sun X; Yang K; Yang L; Kong L; Zhang B; Li F; Li C; Shi B; Hu K; Sun A; Ge J Clin Transl Med; 2021 May; 11(5):e402. PubMed ID: 34047466 [TBL] [Abstract][Full Text] [Related]
7. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner. Yang Z; Cai Z; Yang C; Luo Z; Bao X EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460 [TBL] [Abstract][Full Text] [Related]
8. Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response. Yu F; Wei J; Cui X; Yu C; Ni W; Bungert J; Wu L; He C; Qian Z Nucleic Acids Res; 2021 Jun; 49(10):5779-5797. PubMed ID: 34048572 [TBL] [Abstract][Full Text] [Related]
9. ALKBH5 induces fibroblast-to-myofibroblast transformation during hypoxia to protect against cardiac rupture after myocardial infarction. Yang K; Zhao Y; Hu J; Gao R; Shi J; Wei X; Chen J; Hu K; Sun A; Ge J J Adv Res; 2024 Jul; 61():193-209. PubMed ID: 37689242 [TBL] [Abstract][Full Text] [Related]
10. LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m Fang Y; Wu X; Gu Y; Shi R; Yu T; Pan Y; Zhang J; Jing X; Ma P; Shu Y Clin Transl Med; 2023 Mar; 13(3):e1205. PubMed ID: 36864711 [TBL] [Abstract][Full Text] [Related]
11. Suxiao Jiuxin Pill alleviates myocardial ischemia/reperfusion-induced autophagy via miR-193a-3p/ALKBH5 pathway. Wang D; Wang D; Jin Q; Wang X Phytomedicine; 2024 Mar; 125():155359. PubMed ID: 38301300 [TBL] [Abstract][Full Text] [Related]
12. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner. Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239 [TBL] [Abstract][Full Text] [Related]
13. Alkylation Repair Homolog 5 Regulates N(6)-methyladenosine (m6A) Methylation of Mitsugumin 53 to Attenuate Myocardial Infarction by Inhibiting Apoptosis and Oxidative Stress. Li D; Li L; Dong S; Yu Y; Zhang L; Jiang S J Cardiovasc Pharmacol; 2024 Feb; 83(2):183-192. PubMed ID: 37989146 [TBL] [Abstract][Full Text] [Related]
14. N Liu ZY; Lin LC; Liu ZY; Song K; Tu B; Sun H; Zhou Y; Mao S; Zhang Y; Li R; Yang JJ; Zhao JY; Tao H Cardiovasc Diabetol; 2024 Sep; 23(1):347. PubMed ID: 39342271 [TBL] [Abstract][Full Text] [Related]
15. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918 [TBL] [Abstract][Full Text] [Related]
16. m Liu Y; Zhou T; Wang Q; Fu R; Zhang Z; Chen N; Li Z; Gao G; Peng S; Yang D J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1210-1223. PubMed ID: 35142084 [TBL] [Abstract][Full Text] [Related]
17. The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of Li XC; Jin F; Wang BY; Yin XJ; Hong W; Tian FJ Theranostics; 2019; 9(13):3853-3865. PubMed ID: 31281518 [TBL] [Abstract][Full Text] [Related]
18. ALKBH5 activates FAK signaling through m6A demethylation in Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222 [No Abstract] [Full Text] [Related]
19. Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m Zhang L; Su X Cell Oncol (Dordr); 2022 Jun; 45(3):355-365. PubMed ID: 35579750 [TBL] [Abstract][Full Text] [Related]
20. m Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]